Healthcare provider profile · identity verified

Robert Epstein, M.D.

Internal Medicine · FISHKILL, NY · NPI 1447256383

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	388	141
Amlodipine Besylate	Amlodipine Besylate	349	124
Albuterol Sulfate Hfa	Albuterol Sulfate	242	52
Gabapentin	Gabapentin	238	65
Metformin Hcl	Metformin Hcl	221	82
Losartan Potassium	Losartan Potassium	196	69
Lisinopril	Lisinopril	155	55
Metoprolol Succinate	Metoprolol Succinate	154	54
Hydrochlorothiazide	Hydrochlorothiazide	141	48
Jardiance	Empagliflozin	124	35
Omeprazole	Omeprazole	115	40
Ozempic	Semaglutide	111	27
Rosuvastatin Calcium	Rosuvastatin Calcium	110	40
Tamsulosin Hcl	Tamsulosin Hcl	106	29
Eliquis	Apixaban	102	18
Januvia	Sitagliptin Phosphate	100	23
Levothyroxine Sodium	Levothyroxine Sodium	100	30
Nifedipine Er	Nifedipine	97	27
Simvastatin	Simvastatin	88	27
Montelukast Sodium	Montelukast Sodium	82	22
Sertraline Hcl	Sertraline Hcl	82	21
Pantoprazole Sodium	Pantoprazole Sodium	76	19
Trazodone Hcl	Trazodone Hcl	74	17
Diclofenac Sodium	Diclofenac Sodium	71	26
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	69	13
Tramadol Hcl	Tramadol Hcl	65	22
Finasteride	Finasteride	59	16
Zolpidem Tartrate	Zolpidem Tartrate	59	13
Carvedilol	Carvedilol	57	18
Meloxicam	Meloxicam	54	22
Trulicity	Dulaglutide	51	14
Furosemide	Furosemide	50	17
Metoprolol Tartrate	Metoprolol Tartrate	49	16
Tizanidine Hcl	Tizanidine Hcl	47	21
Famotidine	Famotidine	44	12
Prednisone	Prednisone	42	16
Duloxetine Hcl	Duloxetine Hcl	41	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	41	18
Pregabalin	Pregabalin	41	suppressed
Naproxen	Naproxen	38	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	38	suppressed
Allopurinol	Allopurinol	34	suppressed
Alprazolam	Alprazolam	34	suppressed
Fluticasone Propionate	Fluticasone Propionate	34	14
Glimepiride	Glimepiride	32	11
Entresto	Sacubitril/Valsartan	31	suppressed
Glipizide Er	Glipizide	31	suppressed
Ibuprofen	Ibuprofen	30	13
Mounjaro	Tirzepatide	29	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	27	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	27	suppressed
Oxycodone Hcl	Oxycodone Hcl	27	suppressed
Glipizide	Glipizide	26	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	25	23
Atenolol	Atenolol	25	suppressed
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Clonidine Hcl	Clonidine Hcl	25	suppressed
Hydralazine Hcl	Hydralazine Hcl	25	suppressed
Novolog Flexpen	Insulin Aspart	25	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Latanoprost	Latanoprost	24	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	23	suppressed
Triumeq	Abacavir/Dolutegravir/Lamivudi	23	suppressed
Farxiga	Dapagliflozin Propanediol	22	suppressed
Incruse Ellipta	Umeclidinium Bromide	22	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Meclizine Hcl	Meclizine Hcl	22	suppressed
Meloxicam	Meloxicam, Submicronized	22	suppressed
Metformin Hcl Er	Metformin Hcl	22	suppressed
Spironolactone	Spironolactone	22	suppressed
Valsartan	Valsartan	22	suppressed
Donepezil Hcl	Donepezil Hcl	21	suppressed
Folic Acid	Folic Acid	21	suppressed
Tradjenta	Linagliptin	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Ammonium Lactate	Ammonium Lactate	20	suppressed
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	20	suppressed
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	20	suppressed
Mirtazapine	Mirtazapine	20	suppressed
Tresiba Flextouch U-100	Insulin Degludec	20	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	19	suppressed
Spiriva Respimat	Tiotropium Bromide	19	suppressed
Lidocaine	Lidocaine	18	suppressed
Linzess	Linaclotide	18	suppressed
Procto-Med Hc	Hydrocortisone	18	suppressed
Celecoxib	Celecoxib	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Methotrexate	Methotrexate Sodium	17	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	17	suppressed
Alendronate Sodium	Alendronate Sodium	16	suppressed
Clonazepam	Clonazepam	16	suppressed
Clotrimazole	Clotrimazole	16	suppressed
Ezetimibe	Ezetimibe	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	16	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	11
Venlafaxine Hcl Er	Venlafaxine Hcl	15	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	14	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	14	suppressed
Alcohol Pads	Alcohol Antiseptic Pads	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Rybelsus	Semaglutide	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	11	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	11	suppressed
Bicalutamide	Bicalutamide	11	suppressed
Clopidogrel	Clopidogrel Bisulfate	11	suppressed
Desoximetasone	Desoximetasone	11	suppressed
Dovato	Dolutegravir Sodium/Lamivudine	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Omeprazole-Sodium Bicarbonate	Omeprazole/Sodium Bicarbonate	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error